NCT05232370View on ClinicalTrials.gov

The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 6, 2022

Study Completion Date

January 6, 2022

Conditions
Oxidative Stress
Interventions
DRUG

Angiotensin converting enzyme inhibitor

Angiotensin-converting enzyme inhibitors after Kidney Transplant

DRUG

Angiotensin Receptor Blockers

Angiotensin receptor blockers after Kidney Transplant

Trial Locations (1)

44320

Enrique Rojas Campos, Guadalajara

All Listed Sponsors
lead

Unidad de Investigacion Medica en Enfermedades Renales

OTHER

NCT05232370 - The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients | Biotech Hunter | Biotech Hunter